DL-Phenylalanine, 99%

Name: DL-Phenylalanine, 99%
SKU: A10132.22
Price: 82.50 EUR

CAS: 150-30-1 | C9H11NO2 | 165.19 g/mol

Change view

Quantity:

25 g

100 g

500 g

Try the chem dex^TM web app

This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.

Catalog number A10132.22

also known as A10132-22

Price (EUR)

82,50

Each

Quantity:

100 g

Request bulk or custom format

Price (EUR)

82,50

Each

Chemical Identifiers

CAS150-30-1

IUPAC Name2-amino-3-phenylpropanoic acid

Molecular FormulaC9H11NO2

InChI KeyCOLNVLDHVKWLRT-UHFFFAOYNA-N

SMILESNC(CC1=CC=CC=C1)C(O)=O

Specifications

Specification Sheet

Appearance (Color)White

FormCrystals or powder or crystalline powder

Assay (Non-aqueous acid-base Titration)≥98.5 to ≤101.5%

DL-Phenylalanine is used to relieve cases of minor depression and other mood issues as well as and physical discomforts and pain. It is also used in acupuncture anesthesia, alcohol withdrawal.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
DL-Phenylalanine is used to relieve cases of minor depression and other mood issues as well as and physical discomforts and pain. It is also used in acupuncture anesthesia, alcohol withdrawal.

Solubility
Soluble in water. Insoluble in ethyl ether, benzene.

Notes
Store away from strong oxidizing agents. Keep container tightly closed. Store in cool, dry conditions in well sealed containers.

RUO – Research Use Only

General References:

David R. Wood; Fred W. Reimherr; Paul H. Wender. Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Research. 1985, 16,(1), 21-26.
Tadakazu Tokumura; Masaki Nanbas; Yukl Tsushima; Kimio Tatsuishi; Masanori Kayano; Yoshiharu Machida; and Tsuneji Nagai. Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with dl-phenylalanine as a competing agent. J. Pharm. Sci. 1986, 75,(4), 391-394.